MAZE · Maze Therapeutics, Inc. · Debt
$31.95
-0.63 (-1.93%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$1.81B
Shares
55.55M
Volume · Oct 22
891.18K
Avg daily vol (3M)
644.29K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 4,883,000 | 10-Q filed 2026-08-11 |
| Long-term debt, including current maturities | 2026-06-30 | USD 38,960,000 | 10-Q filed 2026-08-11 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent operating lease liabilities | 2026-06-30 | USD 16,580,000 | 10-Q filed 2026-08-11 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.